CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The INT2ACT project focuses on advancing the use of nucleic acids in medical diagnostics and treatments. It aims to overcome current limitations in detection and delivery methods, paving the way for innovative therapies for diseases like cancer and genetic disorders.
In recent years, nucleic acids (NAs) have contributed significantly to advancing the diagnosis and treatment of diseases such as cancer, infectious and rare diseases.
Breakthrough technologies like genome editing tool CRISPR/Cas9, direct RNA sequencing, multi-omics analysis procedure for NAs analysis, bioinformatics and machine learning for data analysis, and targeted delivery systems based on lipid nanoparticles (LNPs) prove the increasing interest in NAs applicability.
However, the full potent…
UNIVERSITA DEGLI STUDI DI UDINE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
ASOCIACION INSTITUTO BIOGIPUZKOA
Spain, DONOSTIA-SAN SEBASTIAN
Type: Research institute
Activity type: Research Organisations
SME: No
INSTYTUT CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK
Poland, POZNAN
Type: Research institute
Activity type: Research Organisations
SME: No
United Kingdom, Southampton
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
